Description
Product Description
Retatrutide is a synthetic peptide consisting of 42 amino acids. It is a triple-acting agonist that simultaneously activates GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This combined activity distinguishes it from other incretin analogs and is associated with a broader spectrum of metabolic effects. It was originally developed for the treatment of type 2 diabetes and obesity.
Clinical studies have shown significant effects on body weight reduction, improved glycemic control, and beneficial influence on certain cardiovascular risk factors.



